mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at ...

For reasons which are not clear, melanoma has a particular predilection for metastasising to the heart. Half of all cases of disseminated melanoma will have cardiac deposits at necropsy,14 and these ...